CClinicalTrials.gg
TerminatedNCT05708586Updated Mar 27, 2024Results posted

Virtual Reality Decreases Child Anxiety and Pain as Well as Caregiver Anxiety and Pain Perception During Orthopaedic Clinic Office Procedures

An interventional study of Control and Virtual Reality (VR) in Anxiety and Pain, sponsored by University of Michigan. Terminated at 1 site in United States. Open to participants aged 4 Years and older. Per ClinicalTrials.gov, last updated 2024-03-27.

Sponsored by University of Michigan · Not applicable, Interventional, and Supportive care

Why this study was terminated
Preliminary findings showed no significant difference between virtual reality and distraction techniques.

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Dec 2021, registered Jan 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
4 Years and older
Sex
All
01

Study summary

The purpose of this study is to demonstrate that the use of a virtual reality experience can decrease child and caregiver anxiety and pain for simple orthopaedic office procedures.

02

Conditions studied

  • Anxiety
  • Pain

Browse trials for

Keywords

  • Virtual reality
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 66 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Undergoing cast removal, pin removal, or suture removal in study affiliated clinic
  • Less than 17 years old

Exclusion criteria

Exclusion Criteria for pediatric patient:

  • History of seizures
  • Pregnant, have preexisting binocular vision abnormalities or psychiatric disorders, or suffer from a heart condition or other serious medical condition
  • Patients can't have implanted medical devices including cardiac pacemakers, hearing aids and defibrillators

There is no minimum or maximum age for the Caretakers/Parents.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (actual)

Study arms

  • Active comparator
    Control

    Standard comfort given

    Behavioral: Control

  • Experimental
    Virtual Reality (VR)

    Device: Virtual Reality (VR)

Interventions

  • BehavioralControl

    This is the control condition and anxiety is addressed in a standard way of having the care taker calm the child during the intervention.

  • DeviceVirtual Reality (VR)

    The child who is undergoing a procedure uses VR as a distraction during the intervention

06

What researchers measure

Primary outcomes

  1. Child Pain Score

    Assessed by Wong-Baker Children's Faces Pain Scale: The scale shows a series of faces ranging from a happy face at 0 which represents "no hurt" to a crying face at 10 which represents "hurts worst." Based on the faces and descriptions, the patient chooses the face that best describes their level of pain.

    Time frame: Up to 24 hours following procedure

  2. Child Anxiety (7 Years Old and Older)

    Assessed by State-Trait Anxiety Inventory for Children (STAIC): 20 questions with 3 answer options for each question. Scores range from 20 to 60 with 60 being the higher (more or worse) anxiety on self-assessment.

    Time frame: Up to 24 hours following procedure

  3. Child Anxiety (Younger Than 7 Years Old)

    Assessed by Children's Fear Scale: The Children's Fear Scale (CFS) is used to measure the anxiety or fear level of the children. The one-item scale consists of a row of five sex neutral faces ranging from a no fear (neutral) face on the far left to a face showing extreme fear on the far right. Thus, the scale is 1-5 with 1 being least fear and 5 being greatest fear and anxiety.

    Time frame: Up to 24 hours following procedure

Secondary outcomes

  1. Parental Anxiety

    Assessed by State-Trait Anxiety Inventory (STAI): a 20 question inventory where each question is on a Likert scale 1-4. The total range of the inventory is 20-80 with higher scores indicating more anxiety (please note that some questions are reverse coded).

    Time frame: Up to 24 hours following procedure

07

Results

Posted Mar 27, 2024

Participant flow

Participant flow — Overall Study
MilestoneControlVirtual Reality (VR)
Started2835
Completed2835
Not completed00

Outcome measures

PrimaryChild Pain Score

Assessed by Wong-Baker Children's Faces Pain Scale: The scale shows a series of faces ranging from a happy face at 0 which represents "no hurt" to a crying face at 10 which represents "hurts worst." Based on the faces and descriptions, the patient chooses the face that best describes their level of pain.

Time frame:
Up to 24 hours following procedure
Reported as:
Mean · units on a scale
Child Pain Score
units on a scaleControlVirtual Reality (VR)
Pre-Intervention.5 (0 to 6)1.2 (0 to 4)
Post-Intervention1.07 (0 to 10).97 (0 to 6)
PrimaryChild Anxiety (7 Years Old and Older)

Assessed by State-Trait Anxiety Inventory for Children (STAIC): 20 questions with 3 answer options for each question. Scores range from 20 to 60 with 60 being the higher (more or worse) anxiety on self-assessment.

Time frame:
Up to 24 hours following procedure
Reported as:
Mean · units on a scale
Child Anxiety (7 Years Old and Older)
units on a scaleControlVirtual Reality (VR)
Pre-Intervention28.55 (20 to 42)32.88 (20 to 46)
Post-Intervention26.35 (20 to 31)27.96 (20 to 47)
PrimaryChild Anxiety (Younger Than 7 Years Old)

Assessed by Children's Fear Scale: The Children's Fear Scale (CFS) is used to measure the anxiety or fear level of the children. The one-item scale consists of a row of five sex neutral faces ranging from a no fear (neutral) face on the far left to a face showing extreme fear on the far right. Thus, the scale is 1-5 with 1 being least fear and 5 being greatest fear and anxiety.

Time frame:
Up to 24 hours following procedure
Reported as:
Mean · units on a scale
Child Anxiety (Younger Than 7 Years Old)
units on a scaleControlVirtual Reality (VR)
Pre-Intervention1.375 (0 to 4)1.5 (0 to 4)
Post-Intervention.75 (0 to 4)0.875 (0 to 4)
SecondaryParental Anxiety

Assessed by State-Trait Anxiety Inventory (STAI): a 20 question inventory where each question is on a Likert scale 1-4. The total range of the inventory is 20-80 with higher scores indicating more anxiety (please note that some questions are reverse coded).

Time frame:
Up to 24 hours following procedure
Reported as:
Mean · score on a scale
Parental Anxiety
score on a scaleControlVirtual Reality (VR)
Parental Anxiety46.61 (34 to 65)46.91 (37 to 61)

Adverse events

Collected over Up to 24 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Control0/28 (0%)0/28 (0%)0/28 (0%)
Virtual Reality (VR)0/35 (0%)0/35 (0%)0/35 (0%)

Baseline characteristics

Age, Customized
Age, Customized(Participants)ControlVirtual Reality (VR)Total
Age <78715
Age >=7202848
Sex: Female, Male
Sex: Female, Male(Participants)ControlVirtual Reality (VR)Total
Female141630
Male141933
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)ControlVirtual Reality (VR)Total
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)ControlVirtual Reality (VR)Total
United States283563
08

Study locations

1 site
  • University of Michigan
    Ann Arbor, Michigan 48109, United States
09

References and documents

Study documents

  • Study protocol · May 8, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05708586
Lead sponsor
University of Michigan
Responsible party
Noelle Whyte (Clinical Assistant Professor, University of Michigan) — Principal investigator
First posted
Feb 1, 2023
Start date
Dec 8, 2021
Primary completion
Jan 25, 2023
Completion
Jan 25, 2023
Results posted
Mar 27, 2024
Last update
Mar 27, 2024

Study contacts

Noelle Whyte, MD
study chair · University of Michigan

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion